Enapotamab (1912423-61-0): A Research Reagent Overview
Enapotamab, also designated as, known as 1912423-61-0, is a, the research, laboratory reagent, compound, substance gaining attention, prominence, interest within the, scientific community, field for its potential, possible, anticipated utility, application, role in biomedical, immunological, therapeutic investigations. This, It highly specific, selective antibody, protein, molecule targets, binds to, interacts with a, the particular, defined target, antigen, molecule involved, implicated, associated in disease, pathology, immune response processes, mechanisms. Currently, As of now, it, this reagent is primarily, exclusively available, offered for academic, non-commercial research, experimental purposes, applications and is not, isn't approved, sanctioned for clinical, diagnostic use, implementation. Further, Additional studies, investigations are necessary, required to fully, completely elucidate, determine its capabilities, functionality, scope and validate, confirm its value, utility as a, the viable, promising therapeutic, diagnostic tool, agent.
```
```text
Enapotamab: Allowing New Investigation Uses
Enapotamab, a promising medicinal compound, is rapidly opening avenues for exciting investigation uses. Its ability to selectively engage certain cell sorts furnishes scientists with a versatile instrument to analyze sophisticated biological mechanisms. This enables exceptional understandings into condition pathogenesis and supports the creation of advanced assessment and treatment approaches. Furthermore, investigators can now employ enapotamab to explore earlier unreachable cellular locations, leading the course for revolutionary discoveries.
```
Laboratory-Quality Enapotamab Details and Availability
Research-grade enapotamab, previously known as MORab-202 , is available through a limited number of dedicated suppliers, primarily catering to scientific research institutions . Stated specifications typically include a specified purity of ≥98%, as determined by analytical chromatography , with strict control over aggregate impurities. The compound weight is approximately 150 kDa, with a standard formulation consisting of a lyophilized powder to be reconstituted a appropriate buffer. Consecutive consistency is maintained through detailed QC procedures and comprehensive data.
- Cleanliness : ≥98%
- Size: ~150 kDa
- Form : Lyophilized Powder
```
Enapotamab Reagent (1912423-61-0) for Biological Studies
The Enapota reagent, identified by the CAS number 1912423-61-0, is increasingly applied in a variety of biological research. This new antibody-based compound facilitates the examination of defined cellular activities, often related to immune response and specific protein relationships. Researchers are evaluating its potential in elucidating disease pathways and creating therapeutic strategies. Further research are required to fully define its characteristics and optimize its utility in various experimental contexts.
```
Leveraging Enapotamab for Leading-Edge Study
Researchers are rapidly directing focus on enapotamab, website a promising therapeutic, in utilizing its functionality through revolutionary study. The effort holds the chance to deepen our insight of intricate biological functions and perhaps reveal unprecedented treatment strategies in multiple diseases. Further investigation of enapotamab's mode of action promises a substantial influence on the horizon of biomedical study.
Enapotamab (1912423-61-0): The Provider for Premium Reagent Details
Seeking dependable availability to Enapotamab (1912423-61-0)? We present the exceptional compound solution tailored for laboratory applications. The substance is produced with stringent control standards, guaranteeing optimal efficacy in your analyses. We appreciate the critical function that premium chemicals perform in research investigations.
- Concentration guaranteed to defined levels.
- Thorough documents of analysis offered.
- Proper packaging to compound stability.
Connect today to learn more about the chemical compound and it may support scientific projects.